Management of Posterior Cerebral Artery (PCA) Stroke
For PCA stroke, initiate best medical management with IV alteplase (if eligible within 4.5 hours) and aspirin (160-300 mg within 24-48 hours), while reserving endovascular thrombectomy only for highly selected patients with severe deficits (NIHSS >6) after careful consideration of the increased hemorrhage and mortality risks.
Acute Phase Management Algorithm
Immediate Assessment and Thrombolysis
- Administer IV alteplase if the patient presents within 4.5 hours of symptom onset and meets standard eligibility criteria 1
- Start aspirin 160-300 mg within 24-48 hours of stroke onset (delay 24 hours if IV alteplase given) 1
- For patients unable to swallow, use rectal or nasogastric administration 1
Endovascular Therapy Decision-Making
Critical caveat: Unlike anterior circulation strokes, EVT for PCA occlusion lacks robust randomized trial evidence and shows concerning safety signals 2, 3, 4.
Consider EVT only when ALL of the following criteria are met:
- NIHSS score >6 (this threshold shows potential benefit in real-world data) 5, 4
- P1 or proximal P2 segment occlusion confirmed on imaging
- Presentation within 6-24 hours (depending on institutional protocols)
- Large penumbra on advanced imaging suggesting salvageable tissue
- Patient/family understanding that EVT carries 2-fold increased risk of symptomatic hemorrhage (OR 2.32-2.48) and higher mortality risk (OR 1.86) 3, 4, 6
Do NOT pursue EVT for:
- Mild strokes (NIHSS <6) - medical management shows superior outcomes 5, 4
- Distal P2 or P3 occlusions
- Completed large infarcts on imaging
Evidence Synthesis and Nuances
The most recent and highest quality evidence from 2026 meta-analyses reveals a troubling pattern: while EVT achieves early neurological improvement (OR 2.11) and better NIHSS reduction at 24 hours, it fails to improve functional independence at 90 days (OR 0.75 for mRS 0-2) and significantly increases symptomatic intracranial hemorrhage (OR 2.32) and mortality (OR 1.86) 3. This is corroborated by the 2024 meta-analysis showing similar findings 4, 6.
The 2025 real-world analysis of 95,585 patients demonstrates that EVT in unselected PCA stroke patients leads to worse discharge outcomes (24.4% vs 30.7% good outcomes) and higher mortality (8.8% vs 4.9%) 4. However, the critical subgroup finding shows that among moderate-to-severe strokes (NIHSS ≥5), EVT achieved better outcomes (21.7% vs 13.8% good outcomes) with similar mortality 4.
Why PCA Strokes Differ from Anterior Circulation
PCA strokes comprise only 1% of all ischemic strokes but present unique challenges 2:
- Eloquent territory: Small infarcts cause devastating deficits
- Subtle presentations: Patients can have NIHSS of 0 with only headache, vertigo, and truncal ataxia 2
- Delayed recognition: Non-specific symptoms (dizziness, visual changes, nausea) mimic other conditions 2
- Different outcomes: Good clinical outcomes occur in only 20% even with advanced care 2
Blood Pressure Management
- Before recanalization: Maintain systolic BP ≥150 mmHg to preserve collateral flow 1
- After successful recanalization: Target systolic BP <140 mmHg in first 24 hours 1
- Use labetalol or low-dose IV metoprolol for BP control 1
Predictors of Poor Outcome to Monitor
Independent risk factors for poor outcome in medically managed PCA strokes 7:
- Advanced age (OR 1.12 per 5-year increase)
- Higher baseline NIHSS (OR 1.12 per point)
- Larger infarct volume (OR 1.16 per 5 mL)
- Lack of IV thrombolysis use (OR 1.79)
- Incomplete recanalization at 24 hours
- Parenchymal hematoma development (OR 2.37)
Secondary Prevention
For minor PCA strokes, consider dual antiplatelet therapy (aspirin + clopidogrel) for 21 days started within 24 hours for early secondary stroke prevention up to 90 days 1.
Common Pitfalls to Avoid
- Do not substitute aspirin for acute reperfusion therapy in EVT-eligible patients 1
- Do not rely solely on NIHSS - PCA strokes can be devastating with low NIHSS scores due to cranial nerve deficits, ataxia, and visual field cuts not well-captured by the scale 2
- Do not routinely offer EVT based on anterior circulation trial data - PCA territory has fundamentally different risk-benefit profiles 3, 4
- Do not withhold IV alteplase - it remains independently associated with better outcomes (aOR 0.56 for poor outcome when used) 7
The evidence strongly favors medical management as first-line therapy for most PCA strokes, with EVT reserved as a carefully considered option only in severe cases where the potential for meaningful recovery justifies the substantial hemorrhagic and mortality risks.